COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
CGTX on Nasdaq
Shares outstanding
87,819,638
Price per share
$1.35
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
21,268,922
Total reported value
$28,723,974
% of total 13F portfolios
0%
Share change
+10,121,766
Value change
+$14,935,651
Number of holders
68
Price from insider filings
$1.35
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOS Memory SPV I, LP 6.9% $15,027,696 6,059,555 AARON G.L. FLETCHER 19 Sep 2025

As of 30 Sep 2025, 68 institutional investors reported holding 21,268,922 shares of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX). This represents 24% of the company’s total 87,819,638 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) together control 23% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BIOS Capital Management, LP 6.8% 6,000,000 0% 9.1% $8,100,000
DAVENPORT & Co LLC 3.1% 2,689,336 0.02% $3,630,604
VANGUARD GROUP INC 3.1% 2,681,613 +106% 0% $3,620,177
TANG CAPITAL MANAGEMENT LLC 1.4% 1,200,000 0.06% $1,620,000
Chescapmanager LLC 1.1% 997,029 +98% 0.21% $1,345,989
BlackRock, Inc. 1.1% 968,699 +1160% 0% $1,307,743
JANE STREET GROUP, LLC 1.1% 926,150 +6909% 0% $1,250,302
RENAISSANCE TECHNOLOGIES LLC 0.81% 713,500 +640% 0% $963,225
GEODE CAPITAL MANAGEMENT, LLC 0.81% 712,727 +93% 0% $962,527
Hilton Capital Management, LLC 0.66% 581,150 0.06% $784,553
MILLENNIUM MANAGEMENT LLC 0.64% 560,553 0% $756,747
STATE STREET CORP 0.37% 324,983 +167% 0% $438,727
Voss Capital, LP 0.34% 300,000 -33% 0.02% $405,000
Quadrature Capital Ltd 0.3% 263,087 0% $357,798
Graham Capital Management, L.P. 0.26% 226,557 0.01% $305,852
AMERICAN FINANCIAL GROUP INC 0.23% 205,000 0% 0.11% $276,750
GSA CAPITAL PARTNERS LLP 0.22% 196,357 0.02% $265,000
TOCQUEVILLE ASSET MANAGEMENT L.P. 0.19% 162,500 +470% 0% $219,375
NORTHERN TRUST CORP 0.17% 145,241 +206% 0% $196,075
Sigma Planning Corp 0.14% 127,090 -14% 0% $171,572
Alyeska Investment Group, L.P. 0.12% 102,095 0% $137,828
TWO SIGMA INVESTMENTS, LP 0.11% 96,991 +1.9% 0% $130,938
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.1% 84,940 0% $114,669
Corient Private Wealth LLC 0.08% 72,112 0% $97,351
McAdam, LLC 0.08% 72,075 0% $97,301

Institutional Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,035,133 $4,098,031 +$204,859 $1.35 7
2025 Q3 21,268,922 $28,723,974 +$14,935,651 $1.35 68
2025 Q2 11,222,507 $3,499,153 -$132,431 $0.31 47
2025 Q1 11,627,581 $4,889,933 +$37,416 $0.42 48
2024 Q4 11,069,340 $7,761,758 +$583,592 $0.70 43
2024 Q3 4,253,980 $1,990,924 -$2,451,150 $0.47 39
2024 Q2 5,310,353 $8,815,784 -$2,998,365 $1.66 46
2024 Q1 7,090,800 $12,904,468 -$163,293 $1.82 46
2023 Q4 7,154,013 $13,234,773 +$56,990 $1.85 36
2023 Q3 7,236,396 $10,419,453 +$193,945 $1.44 34
2023 Q2 7,100,887 $12,994,058 -$80,891 $1.83 34
2023 Q1 7,140,406 $14,140,001 +$282,874 $1.98 32
2022 Q4 4,800,813 $10,080,423 +$4,060,645 $2.10 32
2022 Q3 5,062,240 $9,614,716 -$263,159 $1.90 28
2022 Q2 4,249,399 $8,946,895 +$5,265,306 $2.11 25
2022 Q1 1,607,898 $4,417,000 +$783,063 $2.75 24
2021 Q4 1,334,454 $8,435,000 +$8,435,000 $6.32 17